(Q42109768)

16 October 2017

Clinical relevance of raised soluble serum interleukin-2 receptor concentrations in cystic fibrosis (English)

1 reference

16 October 2017

0 references

Koller DY

1

1 reference

16 October 2017

Götz M

series ordinal

2

1 reference

16 October 2017

language of work or name

English

0 references

publication date

1 January 1993

1 reference

Archives of Disease in Childhood

16 October 2017

1 reference

16 October 2017

68

1 reference

16 October 2017

1

1 reference

16 October 2017

150

1 reference

Raised serum soluble interleukin-2 receptor concentrations in cystic fibrosis patients with and without evidence of lung disease

16 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1029209

PubMed Central

reference URL

Lymphocyte responsiveness to Pseudomonas aeruginosa in cystic fibrosis: Relationship to status of pulmonary disease in sibling pairs

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1029209

PubMed Central

reference URL

The production of soluble and cellular interleukin-2 receptors by cord blood mononuclear cells following in vitro activation

29 May 2018

1 reference

https://pubmed.ncbi.nlm.nih.gov/8499013

PubMed

reference URL

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1136/ADC.68.1.150-A

1 reference

16 October 2017

1 reference

16 October 2017

PubMed publication ID

8499013

1 reference